FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tiziano Barbui

Research Profile

Disorders

Procedures

Anatomy

Thrombosis

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Tiziano Barbui; Maria Chiara Finazzi; Guido Finazzi
Front-line therapy in polycythemia vera and essential thrombocythemia.
Francesco Passamonti; Maria Luigia Randi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Jürgen Thiele; Alessandro Maria Vannucchi; Elisabetta Antonioli; Tiziano Barbui; Irene Bertozzi; Emanuela Boveri; Veronika Buxhofer-Ausch; Domenica Caramazza; Alessandra Carobbio; Valentina Carrai; Mario Cazzola; Emanuele S G d'Amore; Naseema Gangat; Andrea Gianatti; Francois Girodon; Bettina Gisslinger; Heinz Gisslinger; Curtis A Hanson; Hans Michael Kvasnicka; Margherita Maffioli; Filippo Marino; Leonhard Müllauer; Cristiana Pascutto; Ayalew Tefferi
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.
Tiziano Barbui; Irene Bertozzi; Alessandra Carobbio; Guido Finazzi; Naseema Gangat; Bettina Gisslinger; Heinz Gisslinger; Francesco Passamonti; Alessandro Rambaldi; Maria Luigia Randi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Jürgen Thiele; Alessandro M Vannucchi; Ayalew Tefferi
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tiziano Barbui (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Tiziano Barbui; Maria Chiara Finazzi; Guido Finazzi
Front-line therapy in polycythemia vera and essential thrombocythemia.
Blood reviews 2012;26(5):205-11.
2012: Francesco Passamonti; Maria Luigia Randi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Jürgen Thiele; Alessandro Maria Vannucchi; Elisabetta Antonioli; Tiziano Barbui; Irene Bertozzi; Emanuela Boveri; Veronika Buxhofer-Ausch; Domenica Caramazza; Alessandra Carobbio; Valentina Carrai; Mario Cazzola; Emanuele S G d'Amore; Naseema Gangat; Andrea Gianatti; Francois Girodon; Bettina Gisslinger; Heinz Gisslinger; Curtis A Hanson; Hans Michael Kvasnicka; Margherita Maffioli; Filippo Marino; Leonhard Müllauer; Cristiana Pascutto; Ayalew Tefferi
A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.
Blood 2012;120(6):1197-201.
2012: Tiziano Barbui; Irene Bertozzi; Alessandra Carobbio; Guido Finazzi; Naseema Gangat; Bettina Gisslinger; Heinz Gisslinger; Francesco Passamonti; Alessandro Rambaldi; Maria Luigia Randi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Jürgen Thiele; Alessandro M Vannucchi; Ayalew Tefferi
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.
Blood 2012;120(3):569-71.
2012: Veronika Buxhofer-Ausch; Alessandra Carobbio; Guido Finazzi; Sophie Frantal; Naseema Gangat; Bettina Gisslinger; Heinz Gisslinger; Hans-Michael Kvasnicka; Leonhard Müllauer; Francesco Passamonti; Maria L Randi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Ayalew Tefferi; Jürgen Thiele; Alessandro M Vannucchi; Elisabetta Antonioli; Irene Bertozzi; Tiziano Barbui
Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients.
American journal of hematology 2012;87(7):669-72.
2012: Giovanni Barosi; Ayalew Tefferi; Tiziano Barbui
Do current response criteria in classical Ph-negative myeloproliferative neoplasms capture benefit for patients?
Leukemia 2012;26(5):1148-9.
2012: G Finazzi; Naseema Gangat; Heinz Gisslinger; F Passamonti; A Rambaldi; Maria Luigia Randi; Francesco Rodeghiero; M Ruggeri; Elisa Rumi; Ayalew Tefferi; J Thiele; Alessandro M Vannucchi; Elisabetta Antonioli; I Bertozzi; Veronika Buxhofer-Ausch; A Carobbio; Tiziano Barbui
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.
Leukemia 2012;26(4):716-9.
2012: Alessandra Carobbio; Guido Finazzi; Naseema Gangat; Heinz Gisslinger; Hans Michael Kvasnicka; Maria Luigia Randi; Francesco Passamonti; Alessandro Rambaldi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Ayalew Tefferi; Juergen Thiele; Alessandro M Vannucchi; Elisabetta Antonioli; Irene Bertozzi; Veronika Buxhofer-Ausch; Tiziano Barbui
Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia.
American journal of hematology 2012;87(2):203-4.
2011: Paola Guglielmelli; Maria Letizia Lupo; Elisa Malevolti; Roberto Marchioli; Arianna Masciulli; Ubaldo Occhini; Alessandro Pancrazzi; Simona Paratore; Lisa Pieri; Alessandro Rambaldi; Maria Chiara Susini; Lorenzo Tozzi; Emilio Usala; Alessandro M Vannucchi; Elisabetta Antonioli; Tiziano Barbui; Giovanni Barosi; Niccolò Bartalucci; Flavia Biamonte; Alberto Bosi; Silvia Caglio; Guido Finazzi; Elisabetta Gattoni; Alberto Grossi
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis.
Blood 2011;118(8):2069-76.
2011: Tiziano Barbui; Irene Bertozzi; Emanuela Boveri; Veronika Buxhofer-Ausch; Alessandra Carobbio; Valentina Carrai; Emanuele S G d'Amore; Naseema Gangat; Andrea Gianatti; Heinz Gisslinger; Curtis A Hanson; Filippo Marino; Leonhard Müllauer; Francesco Passamonti; Maria Luigia Randi; Francesco Rodeghiero; Marco Ruggeri; Elisa Rumi; Juergen Thiele; Alessandro M Vannucchi; Elisabetta Antonioli; Ayalew Tefferi
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(23):3179-84.
2011: Tiziano Barbui; Giovanni Barosi; Gunnar Birgegård; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben A Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):761-70.
2011: Animesh Pardanani; A M Vannucchi; F Passamonti; Francisco Cervantes; Tiziano Barbui; Ayalew Tefferi
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.
Leukemia 2011;25(2):218-25.
2011: Roberto Marchioli; Arianna Masciulli; Maria Rosaria Mennitto; Giorgina Specchia; Guido Finazzi; Tiziano Barbui
The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.
Thrombosis 2011;2011():794240.
2010: Elisabetta Antonioli; Alessandra Carobbio; Lisa Pieri; Alessandro Pancrazzi; Paola Guglielmelli; Federica Delaini; Vanessa Ponziani; Niccolò Bartalucci; Lorenzo Tozzi; Alberto Bosi; Alessandro Rambaldi; Tiziano Barbui; Alessandro M Vannucchi
Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia.
Haematologica 2010;95(8):1435-8.
2010: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Giancarla Gerli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Francesco Rodeghiero; Enrico Pogliani; Guido Finazzi; Luigi Gugliotta; Giuseppe Leone; Tiziano Barbui
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
American journal of hematology 2010;85(2):97-100.
2010: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Nicola Vianelli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Emma Cacciola; Francesco Rodeghiero; Enrico M Pogliani; Guido Finazzi; Luigi Gugliotta; Giuseppe Leone; Tiziano Barbui
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
Annals of hematology 2010;89(2):141-6.
2010: Tiziano Barbui; Alessandra Carobbio; Francisco Cervantes; Alessandro M Vannucchi; Paola Guglielmelli; Elisabetta Antonioli; Alberto Alvarez-Larrán; Alessandro Rambaldi; Guido Finazzi; Giovanni Barosi
Thrombosis in primary myelofibrosis: incidence and risk factors.
Blood 2010;115(4):778-82.
2009: Tamara Intermesoli; Federica Delaini; Sara Acerboni; Silvia Salmoiraghi; Orietta Spinelli; Vittoria Guerini; Alessandro M Vannucchi; Silvia Mappa; Giuseppe Rossi; Valentina Rossi; Eros Di Bona; Simona Paratore; Alessandra Carobbio; Alessandro Rambaldi; Tiziano Barbui; Renato Bassan
A short low-dose imatinib trial allows rapid identification of responsive patients in hypereosinophilic syndromes.
British journal of haematology 2009;147(5):681-5.
2009: Alessandra Carobbio; Guido Finazzi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro M Vannucchi; Chiara M Dellacasa; Silvia Salmoiraghi; Federica Delaini; Alessandro Rambaldi; Tiziano Barbui
JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera.
Experimental hematology 2009;37(9):1016-21.
2009: Paola Guglielmelli; Giovanni Barosi; Giorgina Specchia; Alessandro Rambaldi; Francesco Lo Coco; Elisabetta Antonioli; Lisa Pieri; Alessandro Pancrazzi; Vanessa Ponziani; Federica Delaini; Giovanni Longo; Emanuele Ammatuna; Vincenzo Liso; Alberto Bosi; Tiziano Barbui; Alessandro M Vannucchi
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele.
Blood 2009;114(8):1477-83.
2009: Alessandro M Vannucchi; Paola Guglielmelli; Alessandro Rambaldi; Costanza Bogani; Tiziano Barbui
Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.
Journal of cellular and molecular medicine 2009;13(8A):1437-50.
2009: Giovanni Barosi; Gunnar Birgegård; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Jean-Jacques Kiladjian; Eva Lengfelder; Mary Frances McMullin; Francesco Passamonti; John T Reilly; Alessandro M Vannucchi; Tiziano Barbui
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.
Blood 2009;113(20):4829-33.
2009: Renato Bassan; Orietta Spinelli; Elena Oldani; Tamara Intermesoli; Manuela Tosi; Barbara Peruta; Giuseppe Rossi; Erika Borlenghi; Enrico M Pogliani; Elisabetta Terruzzi; Pietro Fabris; Vincenzo Cassibba; Giorgio Lambertenghi-Deliliers; Agostino Cortelezzi; Alberto Bosi; Giacomo Gianfaldoni; Fabio Ciceri; Massimo Bernardi; Andrea Gallamini; Daniele Mattei; Eros Di Bona; Claudio Romani; Anna Maria Scattolin; Tiziano Barbui; Alessandro Rambaldi
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Blood 2009;113(18):4153-62.
2008: Marina Marchetti; Elisabetta Castoldi; Henri M H Spronk; René Van Oerle; Donatella Balducci; Tiziano Barbui; Jan Rosing; Hugo ten Cate; Anna Falanga
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera.
Blood 2008;112(10):4061-8.
2008: Alessandra Carobbio; Guido Finazzi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro M Vannucchi; Federica Delaini; Vittoria Guerini; Marco Ruggeri; Francesco Rodeghiero; Alessandro Rambaldi; Tiziano Barbui
Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia.
Blood 2008;112(8):3135-7.
2008: Martin Griesshammer; Sabine Struve; Tiziano Barbui
Management of Philadelphia negative chronic myeloproliferative disorders in pregnancy.
Blood reviews 2008;22(5):235-45.
2008: Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Pancrazzi; Vittoria Guerini; Giovanni Barosi; Marco Ruggeri; Giorgina Specchia; Francesco Lo Coco; Federica Delaini; Laura Villani; Silvia Finotto; Emanuele Ammatuna; Renato Alterini; Valentina Carrai; Gloria Capaccioli; Simonetta Di Lollo; Vincenzo Liso; Alessandro Rambaldi; Alberto Bosi; Tiziano Barbui
Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia.
Blood 2008;112(3):844-7.
2008: Corrado Tarella; Manuela Zanni; Michele Magni; Fabio Benedetti; Caterina Patti; Tiziano Barbui; Alessandro Pileri; Mario Boccadoro; Fabio Ciceri; Andrea Gallamini; Sergio Cortelazzo; Ignazio Majolino; Salvo Mirto; Paolo Corradini; Roberto Passera; Giovanni Pizzolo; ALESSANDRO MASSIMO GIANNI; Alessandro Rambaldi
Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3166-75.
2008: Alessandra Carobbio; Elisabetta Antonioli; Paola Guglielmelli; Alessandro M Vannucchi; Federica Delaini; Vittoria Guerini; Guido Finazzi; Alessandro Rambaldi; Tiziano Barbui
Leukocytosis and risk stratification assessment in essential thrombocythemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(16):2732-6.
2008: Anna Falanga; Tiziano Barbui; Frederick R Rickles
Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
Seminars in thrombosis and hemostasis 2008;34(2):204-10.
2008: Valerio De Stefano; Tommaso Za; Elena Rossi; Alessandro M Vannucchi; Marco Ruggeri; Elena Elli; Caterina Micò; Alessia Tieghi; Rossella R Cacciola; Cristina Santoro; Giancarla Gerli; Nicola Vianelli; Paola Guglielmelli; Lisa Pieri; Francesca Scognamiglio; Francesco Rodeghiero; Enrico Pogliani; Guido Finazzi; Luigi Gugliotta; Roberto Marchioli; Giuseppe Leone; Tiziano Barbui
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
Haematologica 2008;93(3):372-80.
2008: Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.
Blood 2008;111(2):666-71.
2008: Marina Marchetti; Alfonso Vignoli; Laura Russo; Donatella Balducci; Marcella Pagnoncelli; Tiziano Barbui; Anna Falanga
Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Thrombosis research 2008;121(5):637-45.
2007: Giovanni Barosi; Gaetano Bergamaschi; Monia Marchetti; Alessandro M Vannucchi; Paola Guglielmelli; Elisabetta Antonioli; Margherita Massa; Vittorio Rosti; Rita Campanelli; Laura Villani; Gianluca Viarengo; Elisabetta Gattoni; Giancarla Gerli; Giorgina Specchia; Carmine Tinelli; Alessandro Rambaldi; Tiziano Barbui
JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.
Blood 2007;110(12):4030-6.
2007: Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Giovanni Longo; Alessandro Pancrazzi; Vanessa Ponziani; Costanza Bogani; Pierluigi Rossi Ferrini; Alessandro Rambaldi; Vittoria Guerini; Alberto Bosi; Tiziano Barbui
Prospective identification of high-risk polycythemia vera patients based on JAK2(V617F) allele burden.
Leukemia 2007;21(9):1952-9.
2007: Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegård; Ruben A Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.
Blood 2007;110(4):1092-7.
2007: Monica Galli; Giovanna Borrelli; Eva Marie Jacobsen; Rosa Maria Marfisi; Guido Finazzi; Roberto Marchioli; Finn Wisloff; Stefana Marziali; Olivier Morboeuf; Tiziano Barbui
Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
Blood 2007;110(4):1178-83.
2007: Alessandro M Vannucchi; Elisabetta Antonioli; Paola Guglielmelli; Alessandro Rambaldi; Giovanni Barosi; Roberto Marchioli; Rosa Maria Marfisi; Guido Finazzi; Vittoria Guerini; Fabrizio Fabris; Maria Luigia Randi; Valerio De Stefano; Sabrina Caberlon; Agostino Tafuri; Marco Ruggeri; Giorgina Specchia; Vincenzo Liso; Edoardo Rossi; Enrico Pogliani; Luigi Gugliotta; Alberto Bosi; Tiziano Barbui
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.
Blood 2007;110(3):840-6.
2007: Martino Introna; Gianmaria Borleri; Elena Conti; Marta Franceschetti; Anna Maria Barbui; Raewyn Broady; Erica Dander; Giuseppe Gaipa; Giovanna D'Amico; Ettore Biagi; Matteo Parma; Enrico Pogliani; Orietta Spinelli; Donatella Baronciani; Anna Grassi; Josée Golay; Tiziano Barbui; Andrea Biondi; Alessandro Rambaldi
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study.
Haematologica 2007;92(7):952-9.
2007: Tiziano Barbui; Guido Finazzi
Therapy for polycythemia vera and essential thrombocythemia is driven by the cardiovascular risk.
Seminars in thrombosis and hemostasis 2007;33(4):321-9.
2007: Anna Falanga; Marina Marchetti; Alfonso Vignoli; Donatella Balducci; Laura Russo; Vittoria Guerini; Tiziano Barbui
V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.
Experimental hematology 2007;35(5):702-11.
2007: Orietta Spinelli; Barbara Peruta; Manuela Tosi; Vittoria Guerini; Anna Salvi; Maria Cristina Zanotti; Elena Oldani; Anna Grassi; Tamara Intermesoli; Caterina Micò; Giuseppe Rossi; Pietro Fabris; Giorgio Lambertenghi-Deliliers; Emanuele Angelucci; Tiziano Barbui; Renato Bassan; Alessandro Rambaldi
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Haematologica 2007;92(5):612-8.
2007: Alessandra Carobbio; Guido Finazzi; Vittoria Guerini; Orietta Spinelli; Federica Delaini; Roberto Marchioli; Giovanna Borrelli; Alessandro Rambaldi; Tiziano Barbui
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status.
Blood 2007;109(6):2310-3.
2007: Raffaele Landolfi; Leonardo Di Gennaro; Tiziano Barbui; Valerio De Stefano; Guido Finazzi; Rosa Maria Marfisi; Gianni Tognoni; Roberto Marchioli
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
Blood 2007;109(6):2446-52.
2007: Giovanni Barosi; C Besses; Gunnar Birgegård; Jean Briere; Francisco Cervantes; Guido Finazzi; Heinz Gisslinger; Martin Griesshammer; Luigi Gugliotta; C Harrison; Hans Carl Hasselbalch; Eva Lengfelder; John T Reilly; JJ Michiels; Tiziano Barbui
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.
Leukemia 2007;21(2):277-80.
2007: Frederick R Rickles; Anna Falanga; Pau Montesinos; Miguel A Sanz; Benjamin Brenner; Tiziano Barbui
Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
Thrombosis research 2007;120 Suppl 2():S99-106.
2007: Guido Finazzi; Alessandro Rambaldi; Vittoria Guerini; Alessandra Carobbo; Tiziano Barbui
Risk of thrombosis in patients with essential thrombocythemia and polycythemia vera according to JAK2 V617F mutation status.
Haematologica 2007;92(1):135-6.
2007: Marcello Di Nisio; Tiziano Barbui; Leonardo Di Gennaro; Giovanna Borrelli; Guido Finazzi; Raffaele Landolfi; Giuseppe Leone; Rosa Maria Marfisi; Ettore Porreca; Marco Ruggeri; Anne W S Rutjes; Gianni Tognoni; Alessandro M Vannucchi; Roberto Marchioli
The haematocrit and platelet target in polycythemia vera.
British journal of haematology 2007;136(2):249-59.
2006: Giuseppe Cella; Marina Marchetti; Alfonso Vignoli; Maria Luigia Randi; Graziella Saggiorato; L Pasetto; Antonio Pagnan; Tiziano Barbui; Anna Falanga
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
Leukemia 2006;20(8):1430-4.
2006: Josée Golay; Chiara Cortiana; Massimiliano Manganini; Giovanni Cazzaniga; Anna Salvi; Orietta Spinelli; Renato Bassan; Tiziano Barbui; Andrea Biondi; Alessandro Rambaldi; Martino Introna
The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis.
Haematologica 2006;91(3):322-30.
2006: Alfonso Vignoli; Marina Marchetti; Donatella Balducci; Tiziano Barbui; Anna Falanga
Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
Haematologica 2006;91(2):207-14.
2006: Tiziano Barbui; Guido Finazzi
Myeloproliferative disease in pregnancy and other management issues.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2006;():246-52.
2006: Guido Finazzi; Xylina T Gregg; Tiziano Barbui; Josef T Prchal
Idiopathic erythrocytosis and other non-clonal polycythemias.
Best practice & research. Clinical haematology 2006;19(3):471-82.
2005: Monica Galli; Antonio Nicolucci; Miriam Valentini; Maurizio Belfiglio; Federica Delaini; Claudia Crippa; Anna Maria Barbui; Ursula Giussani; Alessandro Rambaldi; Tiziano Barbui
Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma.
Haematologica 2005;90(12):1643-9.
2005: Eros Di Bona; Enrico Pogliani; Giuseppe Rossi; Teresa Lerede; Anna D'Emilio; Michele Vespignani; Francesco Rodeghiero; Tiziano Barbui; Renato Bassan
Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients.
Leukemia & lymphoma 2005;46(6):879-84.
2005: Guido Finazzi; Roberto Marchioli; V Brancaccio; P Schinco; Finn Wisloff; J Musial; F Baudo; M Berrettini; S Testa; A D'Angelo; G Tognoni; Tiziano Barbui
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS).
Journal of thrombosis and haemostasis : JTH 2005;3(5):848-53.
2005: Anna Falanga; Marina Marchetti; Alfonso Vignoli; Donatella Balducci; Tiziano Barbui
Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera.
Experimental hematology 2005;33(5):523-30.
2005: Alessandro Rambaldi; Emanuela Carlotti; Elena Oldani; Irene Della Starza; Michele Baccarani; Sergio Cortelazzo; Francesco Lauria; Luca Arcaini; Enrica Morra; Alessandro Pulsoni; Luigi Rigacci; Maurizio Rupolo; Francesco Zaja; Pier Luigi Zinzani; Tiziano Barbui; Robin Foa
Quantitative PCR of bone marrow BCL2/IgH+ cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma.
Blood 2005;105(9):3428-33.
2005: Guido Finazzi; Vanesa Caruso; Roberto Marchioli; Giovanni Capnist; Teodoro Chisesi; Carlo Finelli; Luigi Gugliotta; Raffaele Landolfi; Jack Kutti; Heinz Gisslinger; Raphael Marilus; Carlo Patrono; Enrico Pogliani; Maria Luigia Randi; Ana Villegas; Gianni Tognoni; Tiziano Barbui
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.
Blood 2005;105(7):2664-70.
2005: Monica Galli; Tiziano Barbui
Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests.
Seminars in thrombosis and hemostasis 2005;31(1):17-24.
2005: Nicola Vianelli; Monica Galli; Antonio de Vivo; Tamara Intermesoli; Barbara Giannini; Maria Gabriella Mazzucconi; Tiziano Barbui; Sante Tura; Michele Baccaranion
Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Haematologica 2005;90(1):72-7.
2004: Renato Bassan; Giovanni Locatelli; Gianmaria Borleri; Anna Salvi; Tiziano Barbui
Immunophenotypic evaluation of circulating T-cell clones in hypereosinophilic syndromes with or without abnormal CD3 and CD4 lymphocytes.
Haematologica 2004;89(2):238-9.
2004: Tiziano Barbui; Giovanni Barosi; Alberto Grossi; Luigi Gugliotta; Nicola Liberato; Monia Marchetti; Maria Gabriella Mazzucconi; Francesco Rodeghiero; Sante Tura
Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
Haematologica 2004;89(2):215-32.
2004: Simona Pusterla; Sara Previtali; Stefana Marziali; Sergio Cortelazzo; Andrea Rossi; Tiziano Barbui; Monica Galli
Antiphospholipid antibodies in lymphoma: prevalence and clinical significance.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(4):341-6.
2003: Renato Bassan; Orietta Spinelli; Alessandro Rambaldi; Tiziano Barbui
The course of monoclonal 'villous' lymphocytosis over 15 years of follow-up: progression to SLVL or spontaneous clinical but not molecular remission.
Leukemia 2003;17(11):2243-4.
2003: Monica Galli; Davide Luciani; Guido Bertolini; Tiziano Barbui
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome.
Blood 2003;102(8):2717-23.
2003: Marina Marchetti; Alfonso Vignoli; Maria Rosa Bani; Donatella Balducci; Tiziano Barbui; Anna Falanga
All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties.
Haematologica 2003;88(8):895-905.
2003: Anna Falanga; Alfonso Vignoli; Marina Marchetti; Tiziano Barbui
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells.
Leukemia 2003;17(8):1636-42.
2003: Tiziano Barbui; A Falanga
Thalidomide and thrombosis in multiple myeloma.
Journal of thrombosis and haemostasis : JTH 2003;1(3):421-2.
2003: Monica Galli; Davide Luciani; Guido Bertolini; Tiziano Barbui
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
Blood 2003;101(5):1827-32.
2003: Monica Galli; Tiziano Barbui
Antiphospholipid antibodies and thrombosis: strength of association.
The hematology journal : the official journal of the European Haematology Association / EHA 2003;4(3):180-6.
2002: Sara Previtali; Tiziano Barbui; Monica Galli
Anti-beta2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control study.
Thrombosis and haemostasis 2002;88(5):729-32.
2002: Gianpietro Dotti; Roberto Fiocchi; Teresio Motta; Carmelo Mammana; Eliana Gotti; Silvia Riva; Pieremilio Cornelli; Bruno Gridelli; Piera Viero; Elena Oldani; Paolo Ferrazzi; Giuseppe Remuzzi; Tiziano Barbui; Alessandro Rambaldi
Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome.
Transplantation 2002;74(8):1095-102.
2002: Emanuela Carlotti; Francesca Pettenella; Ricardo Amaru; Sarah Slater; T Andrew Lister; Tiziano Barbui; Giuseppe Basso; Giovanni Cazzaniga; Alessandro Rambaldi; Andrea Biondi
Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
British journal of haematology 2002;118(4):1011-8.
2002: Tiziano Barbui
What is the standard treatment in essential thrombocythemia.
International journal of hematology 2002;76 Suppl 2():311-7.
2002: Sergio Cortelazzo; Andrea Rossi; Elena Oldani; Teresio Motta; Roberto Giardini; Pier Luigi Zinzani; Emanuele Zucca; Henry Gomez; Andrés J M Ferreri; Graziella Pinotti; Claudio Chini; liliana devizzi; ALESSANDRO MASSIMO GIANNI; Franco Cavalli; Tiziano Barbui
The modified International Prognostic Index can predict the outcome of localized primary intestinal lymphoma of both extranodal marginal zone B-cell and diffuse large B-cell histologies.
British journal of haematology 2002;118(1):218-28.
2002: Andrés J M Ferreri; Michele Reni; Felice Pasini; Antonello Calderoni; U Tirelli; A Pivnik; G M Aondio; Fabio Ferrarese; H Gomez; Maurilio Ponzoni; Bettina Borisch; Françoise Berger; C Chassagne; Paolo Iuzzolino; A Carbone; J Weis; Ennio Pedrinis; Teresio Motta; Anne Jouvet; Tiziano Barbui; Franco Cavalli; Jean-Yves Blay
A multicenter study of treatment of primary CNS lymphoma.
Neurology 2002;58(10):1513-20.
2002: Anna Falanga; S Toma; Marina Marchetti; R Palumbo; Patrizia Raffo; R Consonni; S Marziali; Giuseppe Dastoli; Tiziano Barbui
Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer.
American journal of hematology 2002;70(1):9-15.
2002: Renato Bassan; A Reseghetti; Sergio Cortelazzo; Andrea Rossi; Maurizio Buelli; Piera Viero; Tiziano Barbui
Gigantic cutaneous lymphoma following Di Bella's therapy.
Haematologica 2002;87(4):EIM13.
2002: Renato Bassan; Teresa Lerede; Gianmaria Borleri; Barbara Chiodini; Andrea Rossi; Maurizio Buelli; Alessandro Rambaldi; Piera Viero; Tiziano Barbui
Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia.
Haematologica 2002;87(3):257-63.
2002: Alessandro Rambaldi; Manuela Lazzari; Cristina Manzoni; Emanuela Carlotti; Luca Arcaini; Michele Baccarani; Tiziano Barbui; Carlo Bernasconi; Giuseppe Dastoli; Giovanna Fuga; Enrica Gamba; Livio Gargantini; Valter Gattei; Francesco Lauria; Mario Lazzarino; Franco Mandelli; Enrica Morra; Alessandro Pulsoni; Michela Ribersani; Pier Luigi Rossi-Ferrini; Maurizio Rupolo; Sante Tura; Vittorina Zagonel; Francesco Zaja; Pier Luigi Zinzani; Gigliola Reato; Robin Foa
Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.
Blood 2002;99(3):856-62.
2002: Renato Bassan; Barbara Chiodini; Teresa Lerede; Ursula Giussani; Elena Oldani; Maurizio Buelli; Andrea Rossi; Piera Viero; Alessandro Rambaldi; Tiziano Barbui
Prolonged administration of all-trans retinoic acid in combination with intensive chemotherapy and G-CSF for adult acute myelogenous leukemia: single-centre pilot study in different risk groups.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(4):193-200.
2002: Anna Maria Barbui; Monica Galli; Gianpietro Dotti; Nadia Belli; Gianmaria Borleri; Giovanna Gritti; Piermario Bellavita; Piera Viero; Benedetto Comotti; Tiziano Barbui; Alessandro Rambaldi
Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma.
British journal of haematology 2002;116(1):202-10.
2001: Josée Golay; M Lazzari; Valeria Facchinetti; Sergio Bernasconi; Gianmaria Borleri; Tiziano Barbui; Alessandro Rambaldi; Martino Introna
CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.
Blood 2001;98(12):3383-9.
2001: Sergio Cortelazzo; Alessandro Rambaldi; Andrea Rossi; Elena Oldani; M Ghielmini; F Benedetti; Corrado Tarella; F Zaglio; Umberto Vitolo; Massimo Di Nicola; Enrico Pogliani; Franco Cavalli; ALESSANDRO MASSIMO GIANNI; Tiziano Barbui
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.
British journal of haematology 2001;114(2):333-41.
2001: Gianpietro Dotti; Alessandro Rambaldi; Roberto Fiocchi; Teresio Motta; G Torre; Piera Viero; Bruno Gridelli; Tiziano Barbui
Anti-CD20 antibody (rituximab) administration in patients with late occurring lymphomas after solid organ transplant.
Haematologica 2001;86(6):618-23.
2001: Gianpietro Dotti; F Gaspari; R Caruso; N Perico; Giuseppe Remuzzi; Tiziano Barbui; Alessandro Rambaldi
Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
Haematologica 2001;86(3):311-5.
2001: Renato Bassan; Enrico Pogliani; P Casula; Giuseppe Rossi; Pietro Fabris; Sergio Morandi; Giorgio Lambertenghi-Deliliers; Michele Vespignani; Teresa Lerede; Alessandro Rambaldi; Gianmaria Borleri; Pierangelo Spedini; Agostino Cortelezzi; T Izzi; Paolo Coser; Giorgio Broccia; Gianmarco Corneo; Tiziano Barbui
Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(2):117-26.
2000: Anna Falanga; Marina Marchetti; Virgilio Evangelista; Alfonso Vignoli; M Licini; M Balicco; Stefano Manarini; G Finazzi; Chiara Cerletti; Tiziano Barbui
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera.
Blood 2000;96(13):4261-6.
2000: Monica Galli; JS Dlott; F Norbis; L Ruggeri; L Cler; D A Triplett; Tiziano Barbui
Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
Thrombosis and haemostasis 2000;84(6):1012-6.
2000: Orietta Spinelli; Ursula Giussani; Gianmaria Borleri; M Lazzari; A Michelato; Gianpietro Dotti; Tiziano Barbui; Alessandro Rambaldi
Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Haematologica 2000;85(11):1153-7.
2000: Ama Z S Rohatiner; Renato Bassan; Roberto Raimondi; John A Amess; S Arnott; A Personen; Francesco Rodeghiero; Tiziano Barbui; Michael Bradburn; M Carter; T Andrew Lister
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):1007-15.
2000: Gianpietro Dotti; Roberto Fiocchi; Teresio Motta; Amando Gamba; E Gotti; Bruno Gridelli; Gianmaria Borleri; C Manzoni; Piera Viero; Giuseppe Remuzzi; Tiziano Barbui; Alessandro Rambaldi
Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
Transplantation 2000;69(5):827-33.
2000: Andrea Bacigalupo; Benedetto Bruno; Paola Saracco; Eros Di Bona; Anna Locasciulli; F Locatelli; Attilio Gabbas; Carlo Dufour; William Arcese; G Testi; Giorgio Broccia; M Carotenuto; Paolo Coser; Tiziano Barbui; Pietro Leoni; A Ferster
Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO).
Blood 2000;95(6):1931-4.
2000: Martino Introna; Anna Maria Barbui; Federica Bambacioni; Chiara Casati; Giuseppe Gaipa; Gianmaria Borleri; Sergio Bernasconi; Tiziano Barbui; Josée Golay; Andrea Biondi; Alessandro Rambaldi
Genetic modification of human T cells with CD20: a strategy to purify and lyse transduced cells with anti-CD20 antibodies.
Human gene therapy 2000;11(4):611-20.
2000: Renato Bassan; Ama Z S Rohatiner; Teresa Lerede; Eros Di Bona; Alessandro Rambaldi; Enrico Pogliani; Giuseppe Rossi; Pietro Fabris; Sergio Morandi; P Casula; M Carter; Giorgio Lambertenghi-Deliliers; T A Lister; Tiziano Barbui
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemia.
The hematology journal : the official journal of the European Haematology Association / EHA 2000;1(4):226-34.
2000: JJ Michiels; Tiziano Barbui; Guido Finazzi; S M Fuchtman; Jack Kutti; J D Rain; Richard T Silver; A Tefferi; J Thiele
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Leukemia & lymphoma 2000;36(3-4):239-53.
1999: Sergio Cortelazzo; Andrea Rossi; F Roggero; Elena Oldani; Emanuele Zucca; C Tondini; Achille Ambrosetti; Felice Pasini; Graziella Pinotti; M Bertini; Umberto Vitolo; M Busetto; Luca Gianni; Franco Cavalli; Tiziano Barbui
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(12):1433-40.
1999: Renato Bassan; Enrico Pogliani; Teresa Lerede; Pietro Fabris; Giuseppe Rossi; Sergio Morandi; P Casula; Giorgio Lambertenghi-Deliliers; Michele Vespignani; T Izzi; Paolo Coser; Gianmarco Corneo; Tiziano Barbui
Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.
Haematologica 1999;84(12):1088-93.
1999: Gianpietro Dotti; Roberto Fiocchi; Teresio Motta; B Facchinetti; B Chiodini; Gianmaria Borleri; G Gavazzeni; Tiziano Barbui; Alessandro Rambaldi
Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8.
Leukemia 1999;13(5):664-70.
1999: Monica Galli; Guido Finazzi; F Norbis; Stefana Marziali; Roberto Marchioli; Tiziano Barbui
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
Thrombosis and haemostasis 1999;81(5):695-700.
1999: Barbara Chiodini; Renato Bassan; Tiziano Barbui
Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
Leukemia & lymphoma 1999;33(5-6):485-97.
1999: Anna Falanga; Marina Marchetti; Virgilio Evangelista; Stefano Manarini; E Oldani; S Giovanelli; M Galbusera; Chiara Cerletti; Tiziano Barbui
Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor.
Blood 1999;93(8):2506-14.
1999: Sergio Cortelazzo; Andrea Rossi; Piermario Bellavita; Elena Oldani; Piera Viero; Maurizio Buelli; Alessandro Rambaldi; Tiziano Barbui
Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):427-32.
1999: Gianpietro Dotti; Enrico Garattini; Gianmaria Borleri; K Masuhara; Orietta Spinelli; Tiziano Barbui; Alessandro Rambaldi
Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
British journal of haematology 1999;105(1):163-72.
1999: Monica Galli; Tiziano Barbui
Antiprothrombin antibodies: detection and clinical significance in the antiphospholipid syndrome.
Blood 1999;93(7):2149-57.
1999: Renato Bassan; Teresa Lerede; Eros Di Bona; Alessandro Rambaldi; Giuseppe Rossi; Enrico Pogliani; Alfio Oriani; Anna D'Emilio; T Izzi; Giorgio Lambertenghi-Deliliers; Gianmarco Corneo; Tiziano Barbui
Induction-consolidation with an idarubicin-containing regimen, unpurged marrow autograft, and post-graft chemotherapy in adult acute lymphoblastic leukaemia.
British journal of haematology 1999;104(4):755-62.
1999: Tiziano Barbui; Guido Finazzi
Management of essential thrombocythemia.
Critical reviews in oncology/hematology 1999;29(3):257-66.
1999: JJ Michiels; Jack Kutti; P Stark; M Bazzan; Luigi Gugliotta; Roberto Marchioli; Martin Griesshammer; Perry van Genderen; Josette Brière; Jean-Jacques Kiladjian; Tiziano Barbui; Guido Finazzi; N I Berlin; T C Pearson; A C Green; S M Fruchtmann; Richard T Silver; E Hansmann; A Wehmeier; Eva Lengfelder; Raffaele Landolfi; Hans Michael Kvasnicka; Hans Carl Hasselbalch; Francisco Cervantes; J Thiele
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
The Netherlands journal of medicine 1999;54(2):46-62.
1999: Renato Bassan; Ama Z S Rohatiner; Alessandro Rambaldi; Teresa Lerede; Eros Di Bona; M Carter; Giuseppe Rossi; Enrico Pogliani; Giorgio Lambertenghi-Deliliers; Pietro Fabris; A Porcellini; T A Lister; Tiziano Barbui
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemia.
Advances in experimental medicine and biology 1999;457():489-99.
1999: Barbara Chiodini; Renato Bassan; Tiziano Barbui
Apoptosis by anthracyclines at therapeutic concentrations in MDR1+ human leukemic cells.
Advances in experimental medicine and biology 1999;457():313-24.
1999: Tiziano Barbui; G Finazzi; M Galli
[Management of quantitative and qualitative platelet defects].
Minerva anestesiologica 1999;65(1-2 Suppl 1):9-19.
1999: Tiziano Barbui; Guido Finazzi
Clinical parameters for determining when and when not to treat essential thrombocythemia.
Seminars in hematology 1999;36(1 Suppl 2):14-8.
1998: Martino Introna; Anna Maria Barbui; Josée Golay; Federica Bambacioni; R Schirò; Sergio Bernasconi; Ferruccio Breviario; Eugenio Erba; Gianmaria Borleri; Tiziano Barbui; Andrea Biondi; Alessandro Rambaldi
Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cells.
British journal of haematology 1998;103(2):449-61.
1998: Renato Bassan; Roberto Raimondi; Teresa Lerede; Anna D'Emilio; Maurizio Buelli; Gianmaria Borleri; A Personeni; Piermario Bellavita; Francesco Rodeghiero; Tiziano Barbui
Outcome assessment of age group-specific (+/- 50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia.
Haematologica 1998;83(7):627-35.
1998: Anna Falanga; R Consonni; Marina Marchetti; G Locatelli; E Garattini; C G Passerini; S G Gordon; Tiziano Barbui
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Blood 1998;92(1):143-51.
1998: Renato Bassan; Teresa Lerede; Maurizio Buelli; Gianmaria Borleri; Piermario Bellavita; Alessandro Rambaldi; Tiziano Barbui
A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
Haematologica 1998;83(5):422-7.
1998: Tiziano Barbui; G Finazzi; Anna Falanga
The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia.
Blood 1998;91(9):3093-102.
1998: S Cortelazzo; M Marchetti; E Orlando; A Falanga; Tiziano Barbui; Michael Buchanan
Aspirin increases the bleeding side effects in essential thrombocythemia independent of the cyclooxygenase pathway: role of the lipoxygenase pathway.
American journal of hematology 1998;57(4):277-82.
1998: Alessandro Rambaldi; Gianmaria Borleri; Gianpietro Dotti; Piermario Bellavita; Ricardo Amaru; Andrea Biondi; Tiziano Barbui
Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: adequacy for autologous and allogeneic transplantation.
Blood 1998;91(6):2189-96.
1998: Tiziano Barbui; G Finazzi
Treatment of polycythemia vera.
Haematologica 1998;83(2):143-9.
1998: Monica Galli; Tiziano Barbui
Prothrombin as cofactor for antiphospholipids.
Lupus 1998;7 Suppl 2():S37-40.
1998: Renato Bassan; Barbara Chiodini; M Zucchetti; Teresa Lerede; P E Cornelli; Sergio Cortelazzo; Tiziano Barbui
Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
Haematologica 1998;83(1):27-33.
1998: Anna Falanga; Mark N Levine; R Consonni; G Gritti; F Delaini; E Oldani; J A Julian; Tiziano Barbui
The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.
Thrombosis and haemostasis 1998;79(1):23-7.
1997: Paolo Rebulla; Guido Finazzi; F Marangoni; Giuseppe Avvisati; Luigi Gugliotta; G Tognoni; Tiziano Barbui; F Mandelli; Girolamo Sirchia
The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
The New England journal of medicine 1997;337(26):1870-5.
1997: Renato Bassan; Barbara Chiodini; Teresa Lerede; V Torri; Gianmaria Borleri; Alessandro Rambaldi; Tiziano Barbui
The role of idarubicin in adult acute lymphoblastic leukaemia: from drug resistance studies to clinical application.
Leukemia & lymphoma 1997;26 Suppl 1():89-97.
1997: Sergio Cortelazzo; Andrea Rossi; Piera Viero; Piermario Bellavita; Roberto Marchioli; Rosa Maria Marfisi; Alessandro Rambaldi; Tiziano Barbui
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
British journal of haematology 1997;99(2):379-85.
1997: Franco Mandelli; Daniela Diverio; Giuseppe Avvisati; A Luciano; Tiziano Barbui; C Bernasconi; Giorgio Broccia; Raffaella Cerri; Michele Falda; Giuseppe Fioritoni; Franco Leoni; Vincenzo Liso; Maria Concetta Petti; Francesco Rodeghiero; Giuseppe Saglio; Maria Luce Vegna; Giuseppe Visani; Ulrich Jehn; Rein Willemze; Petra Muus; Pier Giuseppe Pelicci; Andrea Biondi; Francesco Lo Coco
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.
Blood 1997;90(3):1014-21.
1997: Renato Bassan; Teresa Lerede; Eros Di Bona; Giuseppe Rossi; Enrico Pogliani; Alessandro Rambaldi; Maurizio Buelli; Piera Viero; Francesco Rodeghiero; T Izzi; Gianmarco Corneo; Tiziano Barbui
Granulocyte colony-stimulating factor (G-CSF, filgrastim) after or during an intensive remission induction therapy for adult acute lymphoblastic leukaemia: effects, role of patient pretreatment characteristics, and costs.
Leukemia & lymphoma 1997;26(1-2):153-61.
1997: Corrado Caslini; Orietta Spinelli; Giovanni Cazzaniga; Josée Golay; Luca De Gioia; A Pedretti; Ferruccio Breviario; Ricardo Amaru; Tiziano Barbui; Andrea Biondi; Martino Introna; Alessandro Rambaldi
Identification of two novel isoforms of the ZNF162 gene: a growing family of signal transduction and activator of RNA proteins.
Genomics 1997;42(2):268-77.
1997: Tiziano Barbui; Guido Finazzi; Monica Galli
[Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1997;12(2):76-83.
1997: F Norbis; Tiziano Barbui; M Galli
Diluted Russell's viper venom time and colloidal silica clotting time for the identification of the phospholipid-dependent inhibitors of coagulation.
Thrombosis research 1997;85(5):427-31.
1997: Alessandro Rambaldi; K Masuhara; Gianmaria Borleri; Ricardo Amaru; Maurizio Giannì; Mineko Terao; Tiziano Barbui; Enrico Garattini
Flow cytometry of leucocyte alkaline phosphatase in normal and pathologic leucocytes.
British journal of haematology 1997;96(4):815-22.
1997: Andrea Rossi; Sergio Cortelazzo; Piermario Bellavita; Piera Viero; Renato Bassan; B Comotti; Roberto Marchioli; Rosa Maria Marfisi; Alessandro Rambaldi; Tiziano Barbui
Long-term haematological reconstitution following BEAM and autologous transplantation of circulating progenitor cells in non-Hodgkin's lymphoma.
British journal of haematology 1997;96(3):620-6.
1997: Tiziano Barbui; G Finazzi
Risk factors and prevention of vascular complications in polycythemia vera.
Seminars in thrombosis and hemostasis 1997;23(5):455-61.
1997: Ignazio Majolino; AM Cavallaro; Andrea Bacigalupo; Alessandro Rambaldi; Michele Falda; F Locatelli; Roberto Raimondi; Giulia Pucci; Nicola Mordini; Tiziano Barbui; Franco Locatelli; Francesco Rodeghiero; Giuseppe Irrera; A Indovina; Mauro Valbonesi; Piermario Bellavita; V Tassi; C Perotti; Maurizio Soli; Giuseppe Bresolin
Mobilization and collection of PBSC in healthy donors: a retrospective analysis of the Italian Bone Marrow Transplantation Group (GITMO).
Haematologica 1997;82(1):47-52.
1996: Teresa Lerede; Renato Bassan; A Rossi; Eros Di Bona; Giuseppe Rossi; E M Pogliani; Teresio Motta; V Torri; Maurizio Buelli; B Comotti; Piera Viero; Alessandro Rambaldi; Sergio Cortelazzo; Francesco Rodeghiero; Tiziano Barbui
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphoma.
Haematologica 1996;81(5):442-9.
1996: Renato Bassan; Eros Di Bona; Teresa Lerede; Enrico Pogliani; Giuseppe Rossi; Anna D'Emilio; Maurizio Buelli; Alessandro Rambaldi; Piera Viero; Francesco Rodeghiero; Tiziano Barbui
Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukemia.
Leukemia & lymphoma 1996;22(3-4):295-301.
1996: Renato Bassan; Teresa Lerede; Alessandro Rambaldi; Eros Di Bona; Giuseppe Rossi; Enrico Pogliani; Giorgio Lambertenghi-Deliliers; A Porcellini; Pietro Fabris; Tiziano Barbui
The role of anthracyclines in adult acute lymphoblastic leukaemia.
Leukemia 1996;10 Suppl 2():s58-61.
1996: Alessandro Rambaldi; V Attuati; Renato Bassan; M G Neonato; Piera Viero; R Battista; Eros Di Bona; G Rossi; Enrico Pogliani; M Ruggeri; Ricardo Amaru; A Rivolta; Giovanni Giudici; Andrea Biondi; Tiziano Barbui
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Leukemia & lymphoma 1996;21(5-6):457-66.
1996: Alessandro Rambaldi; Piera Viero; Renato Bassan; Maurizio Buelli; Andrea Rossi; Piermario Bellavita; Orietta Spinelli; Ricardo Amaru; M Micheletti; Gianmaria Borleri; Sergio Cortelazzo; B Comotti; Tiziano Barbui
G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias.
Leukemia 1996;10(5):860-5.
1996: G Finazzi; Vincenzo Brancaccio; Marco Moia; N Ciaverella; Maria Gabriella Mazzucconi; P C Schinco; M Ruggeri; E M Pogliani; G Gamba; E Rossi; F Baudo; C Manotti; A D'Angelo; G Palareti; V De Stefano; M Berrettini; Tiziano Barbui
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.
The American journal of medicine 1996;100(5):530-6.
1996: Marina Marchetti; Anna Falanga; S Giovanelli; E Oldani; Tiziano Barbui
All-trans-retinoic acid increases adhesion to endothelium of the human promyelocytic leukaemia cell line NB4.
British journal of haematology 1996;93(2):360-6.
1996: Renato Bassan; Ricardo Amaru; Alessandro Rambaldi; M Ruggeri; Gianmaria Borleri; Tiziano Barbui
The natural history of monoclonal villous lymphocytosis: a chronic lymphoproliferative disorder of CD11c+ B cells.
Leukemia & lymphoma 1996;21(1-2):181-3.
1996: Tiziano Barbui; Guido Finazzi; A Grassi; R Marchioli
Thrombosis in cancer patients treated with hematopoietic growth factors--a meta-analysis. On behalf of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee of the ISTH.
Thrombosis and haemostasis 1996;75(2):368-71.
1996: Anna Falanga; Marina Marchetti; S Giovanelli; Tiziano Barbui
All-trans-retinoic acid counteracts endothelial cell procoagulant activity induced by a human promyelocytic leukemia-derived cell line (NB4).
Blood 1996;87(2):613-7.
1996: Renato Bassan; Teresa Lerede; Tiziano Barbui
Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults.
Haematologica 1996;81(1):20-36.
1996: Tiziano Barbui; Sergio Cortelazzo; Andrea Rossi; Piera Viero; Piermario Bellavita; Maurizio Buelli; D Fracassetti; Renato Bassan; B Comotti; Roberto Marchioli; Rosa Maria Marfisi; Alessandro Rambaldi
Factors for rapid and sustained hematopoietic reconstitution by circulating progenitor-cell transplantation in non-Hodgkin's lymphoma.
Cancer chemotherapy and pharmacology 1996;38 Suppl():S110-4.
1996: Renato Bassan; Teresa Lerede; Alessandro Rambaldi; Tiziano Barbui
Role of anthracyclines in the treatment of adult acute lymphoblastic leukemia.
Acta haematologica 1996;95(3-4):188-92.
1995: Anna Falanga; Licia Iacoviello; Virgilio Evangelista; D Belotti; R Consonni; Andria D'Orazio; L Robba; Maria Benedetta Donati; Tiziano Barbui
Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid.
Blood 1995;86(3):1072-81.
1995: M Galli; G Finazzi; E M Bevers; Tiziano Barbui
Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
Blood 1995;86(2):617-23.
1995: Tiziano Barbui; G Finazzi; A Remuzzi
Clinical coagulation laboratory and oral anticoagulant therapy treatment. Instrumentation and methodology.
Thrombosis and haemostasis 1995;74(1):511-4.
1995: Renato Bassan; Teresa Lerede; Alessandro Rambaldi; Maurizio Buelli; Piera Viero; Tiziano Barbui
The use of anthracyclines in adult acute lymphoblastic leukemia.
Haematologica 1995;80(3):280-91.
1995: Renato Bassan; Sergio Cortelazzo; Alessandro Rambaldi; P Cornelli; Gianmaria Borleri; Piermario Bellavita; Andrea Biondi; Tiziano Barbui
Autologous PBSC transplant for late onset AML after mafosfamide-purged and TBI-containing autologous BMT.
Bone marrow transplantation 1995;15(5):791-3.
1995: Sergio Cortelazzo; G Finazzi; M Ruggeri; O Vestri; M Galli; F Rodeghiero; Tiziano Barbui
Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.
The New England journal of medicine 1995;332(17):1132-6.
1995: Raffaella Giavazzi; C Di Berardino; A Garofalo; Teresio Motta; A Gobbi; Eugenio Scanziani; Giovanni Giudici; M Galli; J G Mayo; Tiziano Barbui
Establishment of human acute myelogenous leukemia lines secreting interleukin-1 beta in SCID mice.
International journal of cancer. Journal international du cancer 1995;61(2):280-5.
1995: Renato Bassan; R Battista; Piera Viero; Anna D'Emilio; Maurizio Buelli; Anna Montaldi; Alessandro Rambaldi; L Tremul; E Dini; Tiziano Barbui
Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
Leukemia 1995;9(2):238-43.
1995: Renato Bassan; Tiziano Barbui
Remission induction therapy for adults with acute myelogenous leukemia: towards the ICE age?
Haematologica 1995;80(1):82-90.
1994: Renato Bassan; Alessandro Rambaldi; Ricardo Amaru; T Motta; Tiziano Barbui
Unexpected remission of acute myeloid leukaemia after GM-CSF.
British journal of haematology 1994;87(4):835-8.
1994: Tiziano Barbui; G Finazzi
Clinical trials on antiphospholipid syndrome: what is being done and what is needed?
Lupus 1994;3(4):303-7.
1994: R Consonni; Anna Falanga; Tiziano Barbui
Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
British journal of haematology 1994;87(2):321-4.
1994: Anna Falanga; R Consonni; Marina Marchetti; Wojciech Mielicki; A Rambaldi; M Lanotte; S G Gordon; Tiziano Barbui
Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
Leukemia 1994;8(1):156-9.
1994: Guido Finazzi; Tiziano Barbui
Different incidence of venous thrombosis in patients with inherited deficiencies of antithrombin III, protein C and protein S.
Thrombosis and haemostasis 1994;71(1):15-8.
1994: Anna Falanga; Frederick A Ofosu; Sergio Cortelazzo; F Delaini; S Marziali; Tiziano Barbui
Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia.
Seminars in thrombosis and hemostasis 1994;20(4):324-7.
1994: Anna Falanga; Frederick A Ofosu; F Delaini; E Oldani; L Dewar; L Lui; Tiziano Barbui
The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5 Suppl 1():S19-23; discussion 59-64.
1993: Anna Falanga; Tiziano Barbui; F R Rickles; M N Levine
Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis.
Thrombosis and haemostasis 1993;70(3):540-2.
1993: Tiziano Barbui
Leukemia ... the next questions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):631-3.
1993: Alessandro Rambaldi; M Torcia; C A Dinarello; Tiziano Barbui; Federico Cozzolino
Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.
Leukemia 1993;7 Suppl 2():S10-2.
1993: Renato Bassan; R Battista; Anna Montaldi; Alessandro Rambaldi; Anna D'Emilio; Piera Viero; Gianmaria Borleri; Maurizio Buelli; E Dini; Tiziano Barbui
Reinforced HEAV'D therapy for adult acute lymphoblastic leukemia: improved results and revised prognostic criteria.
Hematological oncology 1993;11(4):169-77.
1993: M Razzano; Corrado Caslini; S Cortelazzo; V Battistel; Alessandro Rambaldi; Tiziano Barbui
Clinical and biological effects of erythropoietin treatment of myelodysplastic syndrome.
Leukemia & lymphoma 1993;10(1-2):127-34.
1993: Sergio Cortelazzo; G Finazzi; Piera Viero; M Galli; A Remuzzi; L Parenzan; Tiziano Barbui
Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
Thrombosis and haemostasis 1993;69(4):316-20.
1993: Alessandro Rambaldi; S Bettoni; S Tosi; Giovanni Giudici; R Schirò; G M Borleri; M Abbate; Francesca Chiaffarino; F Colotta; Tiziano Barbui
Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8).
Blood 1993;81(5):1376-83.
1993: Alessandro Rambaldi; S Bettoni; V Rossi; M L Tini; Giovanni Giudici; V Rizzo; Renato Bassan; A Mantovani; Tiziano Barbui; A Biondi
Transcriptional and post-transcriptional regulation of IL-1 beta, IL-6 and TNF-alpha genes in chronic lymphocytic leukaemia.
British journal of haematology 1993;83(2):204-11.
1993: Andrea Biondi; Teresio Motta; A Garofalo; V Rossi; Giovanni Giudici; V Rizzo; Pietro Pioltelli; Gianmarco Corneo; Tiziano Barbui; A Parma
Human T-cell lymphoblastic lymphoma expressing the T-cell receptor gamma/delta established in immune-deficient (bg/nu/xid) mice.
Leukemia 1993;7(2):281-9.
1993: Tiziano Barbui; G Finazzi; A Falanga; R Battista; Renato Bassan
Bleeding and thrombosis in acute lymphoblastic leukemia.
Leukemia & lymphoma 1993;11 Suppl 2():43-7.
1993: Tiziano Barbui; Sergio Cortelazzo; Piera Viero; Maurizio Buelli; R Bassan
Infection and hemorrhage in elderly acute myeloblastic leukemia and primary myelodysplasia.
Hematological oncology 1993;11 Suppl 1():15-8.
1992: E Orlando; Sergio Cortelazzo; M Marchetti; R Sanfratello; Tiziano Barbui
Prolonged bleeding time in patients with lupus anticoagulant.
Thrombosis and haemostasis 1992;68(5):495-9.
1992: Renato Bassan; Maurizio Buelli; Piera Viero; C Minotti; Tiziano Barbui
The management of acute myelogenous leukemia in the elderly: ten-year experience in 118 patients.
Hematological oncology 1992;10(5):251-60.
1992: Renato Bassan; P E Cornelli; R Battista; F Terzi; Maurizio Buelli; Alessandro Rambaldi; Piera Viero; Anna D'Emilio; E Dini; Tiziano Barbui
Intensive retreatment of adults and children with acute lymphoblastic leukemia.
Hematological oncology 1992;10(2):105-10.
1992: Renato Bassan; Andrea Biondi; S Benvestito; M L Tini; M Abbate; P Viero; Tiziano Barbui; Alessandro Rambaldi
Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features.
Cancer 1992;69(2):396-404.
1991: Alessandro Rambaldi; M Torcia; S Bettoni; E Vannier; Tiziano Barbui; A R Shaw; C A Dinarello; Federico Cozzolino
Modulation of cell proliferation and cytokine production in acute myeloblastic leukemia by interleukin-1 receptor antagonist and lack of its expression by leukemic cells.
Blood 1991;78(12):3248-53.
1991: Anna Falanga; R Consonni; P Ruggenenti; Tiziano Barbui
A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura.
British journal of haematology 1991;79(3):474-80.
1991: M Galli; Sergio Cortelazzo; Tiziano Barbui
In vivo efficacy of intravenous gammaglobulins in patients with lupus anticoagulant is not mediated by an anti-idiotypic mechanism.
American journal of hematology 1991;38(3):184-8.
1991: Renato Bassan; M G Neonato; M Abbate; T Motta; Tiziano Barbui; Alessandro Rambaldi
Monoclonal lymphocytosis with villous lymphocytes: a chronic lymphoproliferative disease of CD11c+ B-cells.
Leukemia 1991;5(9):799-806.
1991: Sergio Cortelazzo; Tiziano Barbui
[Essential thrombocythemia: antiaggregants].
Haematologica 1991;76 Suppl 3():371-3.
1991: Tiziano Barbui; Anna Falanga
[Thrombosis and anti-tumor chemotherapy].
Haematologica 1991;76 Suppl 3():276-80.
1991: R Battista; Renato Bassan; Anna D'Emilio; P Dragone; Piera Viero; E Dini; Tiziano Barbui
Short-term remission induction and consolidation therapy for adult acute myelogenous leukemia.
Hematological oncology 1991;9(1):43-52.
1991: M Limonta; Paolo Ubezio; Carlo V Catapano; Valentino Conter; C Costato; G Masera; G Specchia; Vincenzo Liso; Tiziano Barbui; Giovanni Giudici
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients.
Leukemia research 1991;15(1):19-24.
1991: Sergio Cortelazzo; G Finazzi; Maurizio Buelli; A Molteni; Piera Viero; Tiziano Barbui
High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura.
Blood 1991;77(1):31-3.
1991: Renato Bassan; R Battista; Anna D'Emilio; Piera Viero; P Dragone; E Dini; Tiziano Barbui
Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia.
European journal of cancer (Oxford, England : 1990) 1991;27(4):441-7.
1990: Alessandro Rambaldi; M Terao; S Bettoni; M L Tini; Renato Bassan; Tiziano Barbui; E Garattini
Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.
Blood 1990;76(12):2565-71.
1990: Federico Cozzolino; M Torcia; S Bettoni; Donatella Aldinucci; V L Burgio; M C Petti; Anna Rubartelli; Tiziano Barbui; Alessandro Rambaldi
Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
International journal of cancer. Journal international du cancer 1990;46(5):902-7.
1990: G Finazzi; Tiziano Barbui
A retrospective study on oral anticoagulant prophylaxis in 103 Italian patients with hereditary thrombophilia and thrombosis. ad hoc Study Group.
La Ricerca in clinica e in laboratorio 1990;20(4):245-52.
1990: Renato Bassan; Alessandro Rambaldi; M Abbate; A Biondi; P Allavena; Tiziano Barbui; T Bertani
Association of NK-cell lymphoproliferative disease and nephrotic syndrome.
American journal of clinical pathology 1990;94(3):334-8.
1990: M G Alessio; Anna Falanga; R Consonni; Renato Bassan; B Minetti; Maria Benedetta Donati; Tiziano Barbui
Cancer procoagulant in acute lymphoblastic leukemia.
European journal of haematology 1990;45(2):78-81.
1990: M Galli; S Cortelazzo; Tiziano Barbui
Lack of cross-reactivity between anticardiolipin antibodies and glycosaminoglycans.
Thrombosis research 1990;59(2):363-7.
1990: Guido Finazzi; Tiziano Barbui
[Congenital deficiency of antithrombin III].
Haematologica 1990;75 Suppl 2():6-13.
1990: M Limonta; A Biondi; Giovanni Giudici; G Specchia; Carlo V Catapano; G Masera; Tiziano Barbui; Maurizio D'Incalci
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells.
Cancer chemotherapy and pharmacology 1990;26(5):340-2.
1990: Mario Romano; P Viero; S Cortellazzo; Tiziano Barbui; Maria Benedetta Donati; A Poggi
Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Haemostasis 1990;20(3):162-8.
1989: Renato Bassan; Alessandro Rambaldi; Piera Viero; Gianmaria Borleri; Tiziano Barbui
Integrated use of morphology, cytochemistry, and immune marker analysis to identify acute leukaemia subtypes.
Haematologica 1989;74(5):487-90.
1989: Andrea Biondi; P Allavena; V Rossi; Renato Bassan; Tiziano Barbui; E Champagne; T W Mak; M D Minden; Alessandro Rambaldi; A Mantovani
T cell receptor delta gene organization and expression in normal and leukemic natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(3):1009-14.
1989: Anna Falanga; E Shaw; Maria Benedetta Donati; R Consonni; Tiziano Barbui; S Gordon
Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.
Thrombosis research 1989;54(5):389-98.
1989: Alessandro Rambaldi; M Terao; S Bettoni; Renato Bassan; R Battista; Tiziano Barbui; E Garattini
Differences in the expression of alkaline phosphatase mRNA in chronic myelogenous leukemia and paroxysmal nocturnal hemoglobinuria polymorphonuclear leukocytes.
Blood 1989;73(5):1113-5.
1989: Andrea Biondi; V Rossi; Renato Bassan; Tiziano Barbui; S Bettoni; M Sironi; A Mantovani; Alessandro Rambaldi
Constitutive expression of the interleukin-6 gene in chronic lymphocytic leukemia.
Blood 1989;73(5):1279-84.
1989: Renato Bassan; M Pronesti; M Buzzetti; P Allavena; Alessandro Rambaldi; A Mantovani; Tiziano Barbui
Autoimmunity and B-cell dysfunction in chronic proliferative disorders of large granular lymphocytes/natural killer cells.
Cancer 1989;63(1):90-5.
1988: E Orlando; Sergio Cortelazzo; I Nosari; G Lepore; G Pagani; G de Gaetano; Tiziano Barbui
Inhibition of ticlopidine of platelet adhesion to human venous subendothelium in patients with diabetes.
The Journal of laboratory and clinical medicine 1988;112(5):583-8.
1988: Renato Bassan; Alessandro Rambaldi; P Allavena; M Abbate; B Marini; Tiziano Barbui
Association of large granular lymphocyte/natural killer cell proliferative disease and second hematologic malignancy.
American journal of hematology 1988;29(2):85-93.
1988: B Marini; Renato Bassan; Tiziano Barbui
Therapeutic efficacy of danazol in myelodysplastic syndromes.
European journal of cancer & clinical oncology 1988;24(9):1481-9.
1988: Renato Bassan; M Buzzetti; B Marini; Alessandro Rambaldi; P Allavena; Tiziano Barbui
Investigation of chronic lymphocytosis in adults.
American journal of clinical pathology 1988;89(6):783-7.
1988: Anna Falanga; M G Alessio; Maria Benedetta Donati; Tiziano Barbui
A new procoagulant in acute leukemia.
Blood 1988;71(4):870-5.
1988: D Lauri; Elisabetta Dejana; Sergio Cortelazzo; E Orlando; Adriana Zanetti; P Viero; G de Gaetano; Tiziano Barbui
In vitro platelet adhesion to vascular subendothelium: studies in patients with polycythaemia vera.
European journal of haematology 1988;40(3):262-6.
1987: C Mannironi; V Rossi; Andrea Biondi; Paolo Ubezio; G Masera; Tiziano Barbui; Maurizio D'Incalci
Histone H1(0) is synthesized by human lymphocytic leukemia cells but not by normal lymphocytes.
Blood 1987;70(4):1203-7.
1987: Renato Bassan; R Battista; B Comotti; B Minetti; Teodoro Chisesi; E Dini; Tiziano Barbui
Treatment of the lymphoid blast crisis of chronic myeloid leukemia.
European journal of cancer & clinical oncology 1987;23(5):513-5.
1987: Renato Bassan; M Pronesti; M Buzzetti; Piera Viero; B Minetti; B Comotti; Maurizio Buelli; Tiziano Barbui
Surface immunoglobulin intensivity and p67 (CD5) antigen expression define different forms of B-cell chronic lymphocytic leukaemia.
Haematologica 1987;72(3):221-5.
1987: Renato Bassan; B Marini; P Allavena; A Pirelli; Tiziano Barbui
RAEB in a patient with chronic granulated T-lymphocytosis.
British journal of haematology 1987;65(4):503-4.
1987: B Comotti; Renato Bassan; M Buzzetti; G Finazzi; Tiziano Barbui
Multiple myeloma in a pair of twins.
British journal of haematology 1987;65(1):123-4.
1986: Piera Viero; Sergio Cortelazzo; Maurizio Buelli; B Comotti; B Minetti; Renato Bassan; Tiziano Barbui
Thrombotic thrombocytopenic purpura and high-dose immunoglobulin treatment.
Annals of internal medicine 1986;104(2):282.
1985: Tiziano Barbui; Sergio Cortelazzo; Piera Viero; Maurizio Buelli; C Casarotto
Idiopathic thrombocytopenic purpura and pregnancy. Maternal platelet count and antiplatelet antibodies do not predict the risk of neonatal thrombocytopenia.
La Ricerca in clinica e in laboratorio 1985;15(2):139-44.
1985: S Cortellazzo; P Viero; W Buczko; Tiziano Barbui; G de Gaetano
Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
Scandinavian journal of haematology 1985;34(2):146-51.
1985: Maurizio Buelli; Sergio Cortelazzo; Piera Viero; B Minetti; B Comotti; Renato Bassan; Tiziano Barbui
Danazol for the treatment of idiopathic thrombocytopenic purpura.
Acta haematologica 1985;74(2):97-8.
1984: Tiziano Barbui; Renato Bassan; Piera Viero; B Minetti; B Comotti; Maurizio Buelli
Pure white cell aplasia treated by high dose intravenous immunoglobulin.
British journal of haematology 1984;58(3):554-5.
1984: Renato Bassan; B Comotti; B Minetti; Piera Viero; Tiziano Barbui
Concurrent multiple myeloma and chronic lymphocytic leukemia.
American journal of clinical pathology 1984;82(5):624-7.
1984: Renato Bassan; Piera Viero; B Minetti; B Comotti; Tiziano Barbui
Myelokathexis: a rare form of chronic benign granulocytopenia.
British journal of haematology 1984;58(1):115-7.
1984: Sergio Cortelazzo; Piera Viero; C Casarotto; Anna D'Emilio; E Dini; Tiziano Barbui
Bleeding on patients with autoimmune thrombocytopenic purpura and normal platelet count.
Scandinavian journal of haematology 1984;32(4):403-10.
1983: P Viero; S Cortellazzo; C Casarotto; Tiziano Barbui; M Colucci; N Semeraro
Increased production of mononuclear cell procoagulant activity in Hodgkin's disease.
European journal of cancer & clinical oncology 1983;19(11):1539-43.
1983: S Cortellazzo; P Viero; Tiziano Barbui; M Colucci; N Semeraro
Impaired production of mononuclear cell procoagulant activity in chronic lymphocytic leukaemia.
Journal of clinical pathology 1983;36(1):37-40.
1982: Tiziano Barbui; Sergio Cortelazzo; C Casarotto; E Dini
Diagnostic and prognostic significance of platelet-bound IgG measurement in immune thrombocytopenic purpura.
La Ricerca in clinica e in laboratorio 1982;12(4):573-9.
1982: Piera Viero; Maurizio Buelli; B Comotti; B Minetti; Sergio Cortelazzo; Tiziano Barbui
Prednisone corrects the prolonged bleeding time in thrombocythaemia.
Thrombosis and haemostasis 1982;47(2):188.
1981: S Cortellazzo; P Viero; Tiziano Barbui; M Colucci; N Semeraro
Reduced generation of procoagulant activity by endotoxin-stimulated mononuclear cells from patients with chronic myeloid leukaemia.
British journal of haematology 1981;48(3):501-5.
1981: S Cortellazzo; M Colucci; Tiziano Barbui; E Dini; N Semeraro
Reduced platelet factor X-activating activity: a possible contribution to bleeding complications in polycythaemia vera and essential thrombocythaemia.
Haemostasis 1981;10(1):37-50.